Le Lézard
Classified in: Health
Subject: SVY

Global Electroretinography Market to 2027 - Rising Preference For Minimally Invasive Methods


DUBLIN, April 25, 2019 /PRNewswire/ -- The "Electroretinography Market to 2027 - Global Analysis and Forecasts By Product, Application, and Geography" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global electroretinography market is expected to reach US$ 62.72 Mn in 2027 from US$ 35.79 Mn in 2018. The electroretinography market is estimated to grow with a CAGR of 6.7% from 2019-2027.

The market is driven by the factors such as, are rising prevalence of glaucoma among individuals, increasing cases of eye disorders in developed economies and growing geriatric population worldwide in the forecasted period. However, the challenges associated with the technique of electroretinography may limit the growth of the market to a certain extent.

Increasing prevalence of glaucoma is likely to grow the electroretinography market significantly in the forecast period. Glaucoma is a disorder or a disease that damages the eye's optic nerve. The condition occurs when a layer of fluid fills up on the outer side of the eye, creating a pressure and hence leading to damage to optic nerves. Glaucoma often leads to vision loss, eventually causing blindness.

As per the WHO it is stated that glaucoma is the second cause of the blindness in the world it estimates that 4.5 million people worldwide are blind due to glaucoma. In the United States, around 120,000 are blind from glaucoma, accounting for 9% to 12% of all cases of blindness. The geriatric population is the most susceptible to vision loss due to glaucoma However, if it is detected and treated at an early stage, one can avoid vision loss. The worldwide age-standardized prevalence of glaucoma in the population aged 40 years and above is estimated to be around 3.5%. Therefore, owing to the factor the market is likely to boost in the forecast period.

Global electroretinography market was segmented by product and application. The product segment was further divided as fixed electroretinography and portable electroretinography. Based on the application, the market was segmented as clinical and research. During 2018, the clinical segment led the electroretinography market, by application.

Some of the major primary and secondary sources included in the report for the electroretinography market are World Health Organization, Dubai Health Authority, Brazilian Research Association for Vision and Ophthalmology, Korean Ophthalmological Society, Korean Health and Nutrition Examination Survey Royal Society of Medicine, Centers For Disease Control And Prevention, and others.

Key Topics Covered:

1. Introduction

1.1 Scope of the Study

1.2 Report Guidance

1.3 Market Segmentation

2. Global Electroretinography Market - Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Electroretinography Market - Market Landscape

4.1 Overview

4.2 Pest Analysis

5. Global Electroretinography Market - Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Rising Prevalence of Glaucoma Among Individuals

5.1.2 Increasing Cases of Eye Disorders In Developed Economies

5.1.3 Growing Geriatric Population Worldwide

5.2 Key Market Opportunities

5.2.1 Growth In the Global Healthcare Market

5.2.2 Rising Preference For Minimally Invasive Methods

5.3 Key Market Challenges

5.3.1 Risks Associated With Electroretinography

5.4 Impact Analysis of Drivers and Restraints

6. Electroretinography Market - Global Analysis

6.1 Global Electroretinography Market Revenue Forecasts and Analysis

6.2 Global Electroretinography Market, by Geography - Forecasts and Analysis

6.3 Performance of Key Players

6.3.1 Diagnosys Llc

6.3.2 Costruzione Strumenti Oftalmici

7. Global Electroretinography Market Analysis - by Product

7.1 Overview

7.2 Global Electroretinography Market, by Product, 2018 & 2027 (%)

7.3 Fixed Electroretinography Market

7.4 Portable Electroretinography Market

8. Global Electroretinography Market Analysis - by Application

8.1 Overview

8.2 Global Electroretinography Market, by Application, 2018 & 2027 (%)

8.3 Clinical Market

8.4 Research Marke

9. Electroretinography Market Revenue and Forecasts To 2027 - Geographical Analysis

10. Electroretinography Market - Industry Landscape

10.1 Overview

10.2 Comparative Company Analysis

10.3 Growth Strategies Done by the Companies In the Market, (%)

10.4 Organic Developments

10.5 Inorganic Developments

11. Electroretinography Market - Key Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/gou30o

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: